Pakistan’s pharma exports reach $457m

(Web Desk): Pakistan’s pharmaceutical sector is rapidly gaining international recognition. With support from the Special Investment Facilitation Council (SIFC), not only have exports increased, but foreign companies are also showing interest in investing.

Global consumer health company Haleon has announced an investment of $12 million in Pakistan. The company plans to boost production and enhance capacity to meet the growing demand for Panadol in the country.

According to available data, Pakistan’s pharmaceutical exports have reached $457 million during the current fiscal year.

In addition, the combined export volume of various medical products—including pharmaceuticals, surgical items, dietary supplements, and medical devices—has been recorded at $909 million.

According to the Pakistan Pharmaceutical Manufacturers Association (PPMA), a reasonable pricing policy by the government and the decision to deregulate prices have led to a 34% increase in pharmaceutical exports. This policy has encouraged both investment and production within the sector.

Currently, Afghanistan, the Philippines, Sri Lanka, Uzbekistan, and Iraq are among the major importers of Pakistani medicines, while there is also significant export potential in Kenya, Vietnam, Myanmar, and Thailand.

PPMA estimates that Pakistan’s pharmaceutical exports could rise to $1.5 billion by 2030.